ID | 109679 |
Title Alternative | HER2陽性切除不能進行・再発胃癌を対象としたDocetaxel/Cisplatin/S-1/Trastuzumab併用化学療法の忍容性試験
|
Author |
Miyamoto, Hiroshi
University of Tokushima
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Takaoka, Toshi
University of Tokushima
Miyoshi, Jinsei
University of Tokushima
Kagawa, Miwako
University of Tokushima
Ohnuma, Hiroyuki
Sapporo Medical University
Hirakawa, Masahiro
Sapporo Medical University
Kubo, Tomohiro
Sapporo Medical University
Osuga, Takahiro
Sapporo Medical University
Sagawa, Tamotsu
Hokkaido Cancer Center
Sato, Yasuhiro
Hokkaido Cancer Center
Takahashi, Yasuo
Hokkaido Cancer Center
Katsuki, Shinichi
Otaru Ekisaikai Hospital
Okuda, Toshinori
Oji General Hospital
Takimoto, Rishu
Sapporo Medical University
Kobune, Masayoshi
Sapporo Medical University
Nobuoka, Takayuki
Sapporo Medical University
Hirata, Koichi
Sapporo Medical University
Kato, Junji
Sapporo Medical University
Takayama, Tetsuji
University of Tokushima
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | Gastric cancer
HER2
trastuzumab
feasibility
|
Content Type |
Thesis or Dissertation
|
Journal Title |
Cancer Chemotherapy and Pharmacology
|
ISSN | 14320843
03445704
|
NCID | AA1161885X
AA00598397
|
Publisher | Springer naure
|
Volume | 76
|
Issue | 2
|
Start Page | 375
|
End Page | 382
|
Published Date | 2015-06-23
|
Remark | 内容要旨・審査要旨・論文要約の公開:
内容要旨・審査要旨 : LID201606031001.pdf 論文要約 : LID201606031002.pdf 本論文は,著者Yasuhiro Mitsuiの学位論文として提出され, 学位審査・授与の対象となっている。 |
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
jpn
|
TextVersion |
その他
|
MEXT report number | 甲第2897号
|
Diploma Number | 甲医第1271号
|
Granted Date | 2016-03-23
|
Degree Name |
Doctor of Medical Science
|
Grantor |
Tokushima University
|
departments |
University Hospital
Medical Sciences
|